AU715289B2 - Immortalized lines of endothelial brain cells and therapeutic applications thereof - Google Patents
Immortalized lines of endothelial brain cells and therapeutic applications thereof Download PDFInfo
- Publication number
- AU715289B2 AU715289B2 AU36575/95A AU3657595A AU715289B2 AU 715289 B2 AU715289 B2 AU 715289B2 AU 36575/95 A AU36575/95 A AU 36575/95A AU 3657595 A AU3657595 A AU 3657595A AU 715289 B2 AU715289 B2 AU 715289B2
- Authority
- AU
- Australia
- Prior art keywords
- cells
- endothelial
- brain
- gene
- cell lines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/04—Immortalised cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Psychology (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR94/12078 | 1994-10-10 | ||
FR9412078A FR2726005B1 (fr) | 1994-10-10 | 1994-10-10 | Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques |
PCT/FR1995/001313 WO1996011278A1 (fr) | 1994-10-10 | 1995-10-09 | Lignees immortalisees de cellules endotheliales cerebrales et leurs applications therapeutiques |
Publications (2)
Publication Number | Publication Date |
---|---|
AU3657595A AU3657595A (en) | 1996-05-02 |
AU715289B2 true AU715289B2 (en) | 2000-01-20 |
Family
ID=9467723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU36575/95A Ceased AU715289B2 (en) | 1994-10-10 | 1995-10-09 | Immortalized lines of endothelial brain cells and therapeutic applications thereof |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0787197A1 (fr) |
JP (1) | JPH10507074A (fr) |
AU (1) | AU715289B2 (fr) |
CA (1) | CA2202066A1 (fr) |
FR (1) | FR2726005B1 (fr) |
NZ (1) | NZ293994A (fr) |
WO (1) | WO1996011278A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2318379A1 (fr) * | 1998-01-12 | 1999-07-15 | Betagene, Inc. | Lignees cellulaires recombinees pour le criblage de medicaments |
US6093553A (en) * | 1998-11-25 | 2000-07-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | Immortalized brain endothelial cells |
EP1135466A2 (fr) * | 1998-11-30 | 2001-09-26 | Neurotech S.A. | Cellules non neuronales de mammiferes modifiees en vue du stockage et de la liberation d'un neurotransmetteur |
FR2787463B1 (fr) * | 1998-12-21 | 2001-03-30 | Neurotech | Preparation de cellules de mammifere eventuellement transfectees avec un gene codant pour une substance active et les compositions les contenant |
FR2787464B1 (fr) * | 1998-12-21 | 2003-01-10 | Neurotech | Compositions pharmaceutiques comprenant des cellules endotheliales immortalisees pour la detection et/ou le traitement des sources angiogeniques et tout particulierement des cancers |
EP1163912B1 (fr) * | 1999-03-23 | 2007-10-31 | Takara Bio Inc. | Therapeutique genique |
AU2001259422A1 (en) * | 2000-05-03 | 2001-11-12 | Neurotech Sa | Immortalized lines of endothelial brain cells and therapeutic application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989005345A1 (fr) * | 1987-12-11 | 1989-06-15 | Whitehead Institute For Biomedical Research | Modification genetique de cellules endotheliales |
WO1993006222A1 (fr) * | 1991-09-24 | 1993-04-01 | Centre National De La Recherche Scientifique (Cnrs) | Lignees de cellules endotheliales cerebrales immortalisees avec un oncogene |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3418982B2 (ja) * | 1990-10-31 | 2003-06-23 | ソマティクス セラピー コーポレイション | 内皮細胞の遺伝的変性 |
WO1992017569A1 (fr) * | 1991-04-04 | 1992-10-15 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Immortalisation de cellules endotheliales |
US5336615A (en) * | 1992-01-06 | 1994-08-09 | Yale University | Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity |
AU3429993A (en) * | 1992-01-10 | 1993-08-03 | Georgetown University | A method of administering genetically engineered endothelial cells to sites of angiogenesis for effecting genetic therapy |
GB9222931D0 (en) * | 1992-11-02 | 1992-12-16 | Sandoz Ltd | Organic compounds |
-
1994
- 1994-10-10 FR FR9412078A patent/FR2726005B1/fr not_active Expired - Fee Related
-
1995
- 1995-10-09 EP EP95934188A patent/EP0787197A1/fr not_active Withdrawn
- 1995-10-09 AU AU36575/95A patent/AU715289B2/en not_active Ceased
- 1995-10-09 NZ NZ293994A patent/NZ293994A/xx unknown
- 1995-10-09 JP JP8512390A patent/JPH10507074A/ja not_active Ceased
- 1995-10-09 CA CA002202066A patent/CA2202066A1/fr not_active Abandoned
- 1995-10-09 WO PCT/FR1995/001313 patent/WO1996011278A1/fr not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989005345A1 (fr) * | 1987-12-11 | 1989-06-15 | Whitehead Institute For Biomedical Research | Modification genetique de cellules endotheliales |
WO1993006222A1 (fr) * | 1991-09-24 | 1993-04-01 | Centre National De La Recherche Scientifique (Cnrs) | Lignees de cellules endotheliales cerebrales immortalisees avec un oncogene |
Non-Patent Citations (1)
Title |
---|
MED. ABS. 7908023 * |
Also Published As
Publication number | Publication date |
---|---|
EP0787197A1 (fr) | 1997-08-06 |
JPH10507074A (ja) | 1998-07-14 |
CA2202066A1 (fr) | 1996-04-18 |
AU3657595A (en) | 1996-05-02 |
WO1996011278A1 (fr) | 1996-04-18 |
NZ293994A (en) | 1999-02-25 |
FR2726005A1 (fr) | 1996-04-26 |
FR2726005B1 (fr) | 1997-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Takahashi et al. | Widespread integration and survival of adult-derived neural progenitor cells in the developing optic retina | |
Palmer et al. | The adult rat hippocampus contains primordial neural stem cells | |
US6680198B1 (en) | Engraftable human neural stem cells | |
Villa et al. | Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS | |
Chicoine et al. | Mitogens as motogens | |
Pozas et al. | Age-dependent effects of secreted Semaphorins 3A, 3F, and 3E on developing hippocampal axons: in vitro effects and phenotype of Semaphorin 3A (−/−) mice | |
Tornatore et al. | Expression of tyrosine hydroxylase in an immortalized human fetal astrocyte cell line: in vitro characterization and engraftment into the rodent striatum | |
JPH06503968A (ja) | 遺伝子治療のためのレトロウイルスのベクター | |
Lal et al. | Endothelial cell implantation and survival within experimental gliomas. | |
CA2095300C (fr) | Utilisation de cellules genetiquement modifiees pour traiter des defectuosites, des maladies ou des dommages affectant le systeme nerveux central | |
Cunningham et al. | Nerve growth factor released by transgenic astrocytes enhances the function of adrenal chromaffin cell grafts in a rat model of Parkinson's disease | |
Strömberg et al. | Target‐specific outgrowth from human mesencephalic tissue grafted to cortex or ventricle of immunosuppressed rats | |
AU715289B2 (en) | Immortalized lines of endothelial brain cells and therapeutic applications thereof | |
KR19990044606A (ko) | 다능성 신경상피세포를 사용한 신경 이식 | |
EP1090105B1 (fr) | Cellules souches non-embryonnaires neuronales ependymaires et methode servant a isoler celles-ci | |
Ojeifo et al. | Angiogenesis-directed implantation of genetically modified endothelial cells in mice | |
Shafit‐Zagardo et al. | Novel microtubule‐associated protein‐2 isoform is expressed early in human oligodendrocyte maturation | |
Pascual et al. | Coordinated functions of Netrin-1 and Class 3 secreted Semaphorins in the guidance of reciprocal septohippocampal connections | |
Quinonero et al. | Gene transfer to the central nervous system by transplantation of cerebral endothelial cells | |
US20040018619A1 (en) | Immortalized lines of endothelial brain cells and therapeutic applications thereof | |
Arnhold et al. | Intracerebral transplantation and successful integration of astrocytes following genetic modification with a high-capacity adenoviral vector | |
WO2001083716A2 (fr) | Lignees immortalisees de cellules encephaliques endotheliales et applications therapeutiques de ces dernieres | |
US20040115807A1 (en) | O-2a progenitors multipotent cells from neurohypophysis | |
Williams | The cellular and molecular changes occurring in the degenerating and regenerating olfactory system | |
Verity | Myelin protein gene expression in developing normal mice, dysmyelinating mutants and an immortalized oligodendrocyte cell line |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |